Founded in South Korea, SK Bioscience Co.,Ltd. is a biotech company dedicated to advancing public health through the development and production of high-quality vaccines and biopharmaceuticals. The company's core mission is to innovate and provide effective solutions for preventing infectious diseases. Their product portfolio includes vaccines such as SKYCellflu prefilled syringes, SKYCellflu quadrivalent prefilled syringes, and varicella drugs, which are marketed primarily within South Korea.
SK Bioscience has garnered attention for its collaborations with global health organizations and pharmaceutical giants. Notable achievements include the successful development and distribution of various vaccines that have significantly contributed to public health. The company's impact is evident in its role in enhancing vaccine accessibility and efficacy, positioning it as a key player in the biopharmaceutical industry.
